Thoratec Announces Presentations At Investor Conferences For December 2013
PLEASANTON, Calif., Nov. 27, 2013
PLEASANTON, Calif., Nov. 27, 2013 /PRNewswire/ --Thoratec Corporation
(NASDAQ: THOR), a world leader in device-based mechanical circulatory support
therapies to save, support and restore failing hearts, said today it will be
participating in two upcoming investor conferences.
On Wednesday, December 4, the company will participate in the Piper Jaffray
25^th Annual Health Care Conference. Taylor C. Harris, Vice President and
Chief Financial Officer, will provide an update on the company, beginning at
12:00 p.m., Eastern Standard Time (9:00 a.m., Pacific Standard Time). A
webcast of the presentation will be available at
http://www.media-server.com/m/p/2k89k7xb, or on the company's website at
On Tuesday, December 10, Thoratec will participate in the Oppenheimer 24^th
Annual Healthcare Conference. The presentation by Taylor C. Harris, Vice
President and Chief Financial Officer, will begin at 2:10 p.m., Eastern
Standard Time (11:10 a.m., Pacific Standard Time). A webcast of the
presentation will be available at
http://www.veracast.com/webcasts/opco/healthcare2013/08112471883.cfm, or on
the company's website at http://www.thoratec.com.
Thoratec is a world leader in therapies to address advanced-stage heart
failure. The company's products include the HeartMate® LVAS (Left Ventricular
Assist System) and Thoratec® VAD (Ventricular Assist Device) with more than
20,000 devices implanted in patients suffering from heart failure. Thoratec
also manufactures and distributes the CentriMag® and PediMag®/PediVAS® product
lines. Thoratec is headquartered in Pleasanton, California. For more
information, visit the company's website at http://www.thoratec.com.
Thoratec, the Thoratec logo, HeartMate and HeartMate II are registered
trademarks of Thoratec Corporation and IVAD is a trademark of Thoratec
Corporation. CentriMag and PediMag are registered trademarks of Thoratec LLC,
and PediVAS is a registered trademark of Thoratec Switzerland GmbH.
SOURCE Thoratec Corporation
Contact: Neil Meyer, Director of Investor Relations, Thoratec Corporation,
Press spacebar to pause and continue. Press esc to stop.